Lxlabs HyperVM 2.0 Login Page frm_emessage cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 4.1 | $0-$5k | 0.00 |
Summary
A vulnerability was found in Lxlabs HyperVM 2.0. It has been classified as problematic. Affected by this issue is some unknown functionality of the component Login Page. Performing a manipulation of the argument frm_emessage results in cross site scripting. This vulnerability is known as CVE-2007-6287. Remote exploitation of the attack is possible. No exploit is available.
Details
A vulnerability was found in Lxlabs HyperVM 2.0. It has been classified as problematic. This affects an unknown code block of the component Login Page. The manipulation of the argument frm_emessage with an unknown input leads to a cross site scripting vulnerability. CWE is classifying the issue as CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. This is going to have an impact on integrity. The summary by CVE is:
Cross-site scripting (XSS) vulnerability in the login page in Lxlabs HyperVM 2.0 allows remote attackers to inject arbitrary web script or HTML via the frm_emessage parameter, a different vector than CVE-2006-6649. NOTE: the provenance of this information is unknown; the details are obtained solely from third party information.
The weakness was published 12/10/2007 (Website). It is possible to read the advisory at securityfocus.com. This vulnerability is uniquely identified as CVE-2007-6287 since 12/10/2007. It is possible to initiate the attack remotely. No form of authentication is needed for exploitation. It demands that the victim is doing some kind of user interaction. Technical details of the vulnerability are known, but there is no available exploit. The attack technique deployed by this issue is T1059.007 according to MITRE ATT&CK.
It is declared as highly functional.
The vulnerability is also documented in the databases at X-Force (38926), SecurityFocus (BID 26751†) and Secunia (SA27893†). Be aware that VulDB is the high quality source for vulnerability data.
Product
Vendor
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 4.1
VulDB Base Score: 4.3
VulDB Temp Score: 4.1
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Highly functional
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
12/07/2007 🔍12/07/2007 🔍
12/10/2007 🔍
12/10/2007 🔍
12/10/2007 🔍
03/16/2015 🔍
09/12/2018 🔍
Sources
Advisory: securityfocus.com⛔Status: Confirmed
CVE: CVE-2007-6287 (🔍)
GCVE (CVE): GCVE-0-2007-6287
GCVE (VulDB): GCVE-100-39975
X-Force: 38926 - HyperVM login page cross-site scripting
SecurityFocus: 26751 - Lxlabs HyperVM Cross-Site Scripting Vulnerability
Secunia: 27893 - HyperVM "frm_emessage" Cross-Site Scripting Vulnerability, Less Critical
Entry
Created: 03/16/2015 13:43Updated: 09/12/2018 11:19
Changes: 03/16/2015 13:43 (51), 09/12/2018 11:19 (7)
Complete: 🔍
Cache ID: 216::103
Be aware that VulDB is the high quality source for vulnerability data.
No comments yet. Languages: en.
Please log in to comment.